Fund Card

Fund Card

Nippon India Pharma Fund(G)

As on Apr-12-2021 change fund
264.82  down-1.92 (-0.72%)

fund objective

The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

riskometer

Investors understand that their principal will be at very high risk

5-Years History
financial year2016-20172017-20182018-20192019-20202020-2021
NAV in Rs (as on 31-Mar-2021)135.25133.66151.74143.39250.18
Net Assets(Rs Crores) (as on 31-Mar-2021) 1444.86 1875.94 2687.68 2189.84 4260.99
Scheme Returns(%)(Absolute)3.13-2.1113.53-5.8377.36
B'mark Returns(%)(Absolute)1.71-14.457.46-15.0279.08
Category Rank48/5651/629/7314/7532/75
Quarterly performance - Last 5 years (Absolute Ret. in %)
financial year Q1 Q2 Q3 Q4
2020-202131.5919.5012.24-1.15
2019-2020-6.50-1.118.38-5.70
2018-20196.9510.70-5.501.47
2017-2018-4.950.1912.03-7.37
2016-20172.177.77-7.220.87
Top 10 holdings
company (%)
Sun Pharmaceutical Industries...11.23 
Aurobindo Pharma Ltd.9.93 
Dr. Reddys Laboratories Ltd.9.80 
Cipla Ltd.9.76 
Lupin Ltd.9.58 
Divis Laboratories Ltd.8.93 
Fortis Healthcare Ltd.7.28 
Gland Pharma Ltd.6.39 
Cadila Healthcare Ltd.5.59 
Thyrocare Technologies Ltd.3.92 

Category

Sector Funds

Launch Date

05-Jun-04

Scheme Benchmark

S&P BSE HEALTH CARE - TRI

AUM ( in Cr.)

4,260.99

portfolio price to book value

5.03

investing style?

Large Growth

fund manager?

Sailesh Raj Bhan,Kinjal Desai

inception date (regular plan)

05-Jun-04

expense ratio (regular plan) %

1.97

Alpha [%]

0.13

Beta [%]

0.32

Top 10 sectors
sectors (%)
Pharmaceuticals & Drugs82.02
Hospital & Healthcare Services16.84
Miscellaneous0.52

Historical NAV Chart with Benchmark

to go
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • maximum
performance comparision with similar schemes
scheme name investment style inception date AUM in Cr. 1W(%) 1M(%) 3M(%) 1Y(%) 3Y(%) 5Y(%) 10Y(%) since inception
Nippon India Pharma Fund(G)Large-Growth 05-Jun-20044,260.993.886.781.5054.6924.1114.7016.9521.45BUYSIP
Tata India Pharma & Healthcare Fund-Reg(G)Large-Growth 28-Dec-2015435.034.436.270.5646.2921.5910.25NA8.64BUYSIP
UTI Healthcare Fund-Reg(G)Large-Growth 01-Aug-2005618.133.745.42-0.2551.8820.4010.7913.8918.59BUYSIP
SBI Healthcare Opp Fund-Reg(G)Large-Growth 14-Jul-19991,563.953.514.51-0.3151.5319.388.0916.4415.71BUYSIP
DSP Healthcare Fund-Reg(G)Large-Growth 30-Nov-20181,109.583.934.821.7663.67NANANA34.33BUYSIP
Mirae Asset Healthcare Fund-Reg(G)Large-Growth 02-Jul-20181,268.974.846.062.2857.82NANANA27.81BUYSIP
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Large-Growth 13-Jul-20182,213.634.364.420.1156.58NANANA24.35BUYSIP
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Large-Growth 10-Jul-2019454.914.246.270.2443.28NANANA34.99BUYSIP
IDBI Healthcare Fund-Reg(G)Large-Growth 28-Feb-201964.433.814.38-1.0040.45NANANA28.11BUYSIP

Copyright © 2021 Vedant Asset. All Right Reserved.

Mutual Fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not an indicator of future returns. ARN-104974